Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Natalia Lloveras"'
Autor:
Gemma Osca-Gelis, Montserrat Puig-Vives, Marc Saez, David Gallardo, Natalia Lloveras, Rafael Marcos-Gragera
Publikováno v:
Haematologica, Vol 98, Iss 8 (2013)
Externí odkaz:
https://doaj.org/article/26475b5272984e4ebdf25f37367d18f3
Autor:
Antoni Garcia, Antonia Sampol, Rocío Rodríguez-Romanos, Rosa Coll, Gemma Osca, Ana Garrido, Joan Bargay, Teresa Quiñones, Jordi Esteve, Montse Arnan, Olga Salamero, Johana Díaz-Santa, Inma Heras, Lourdes Escoda, Jorge Sierra, Susanna Vives, Natalia Lloveras, Marta Pratcorona, Mar Tormo, David Cruz, David Gallardo, Carla Moret
Publikováno v:
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
The treatment of acute myeloid leukemia (AML) is adjusted according to cytogenetic risk factors and molecular markers. Cytarabine remains the main drug to treat AML, and several studies have explored the prognostic relevance of the genotype of cytara
Autor:
Yolanda Gonzalez-Montes, Gemma Osca-Gelis, Rocío Rodriguez-Romanos, Alicia Villavicencio, Marta González-Bártulos, Francesca Llopis, Victòria Clapes, Albert Oriol, Anna Sureda, Lourdes Escoda, Josep Sarrà, Ana Garzó, Natàlia Lloveras, Beatriz Gómez, Isabel Granada, David Gallardo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Immune dysfunction in patients with MM affects both the innate and adaptive immune system. Molecules involved in the immune response pathways are essential to determine the ability of cancer cells to escape from the immune system surveillance. Howeve
Externí odkaz:
https://doaj.org/article/5c94d37e316b4400bb753f5edca4b0d9
Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study
Autor:
Marc Saez, Natalia Lloveras, David Gallardo, Rafael Marcos-Gragera, Gemma Osca-Gelis, Ramon Guardia, Montserrat Puig-Vives
Publikováno v:
Leukemia & Lymphoma. 56:896-902
Myeloid malignancies (MMs) are heterogeneous groups of diseases which present different prognoses. Using data from the population-based Girona Cancer Registry, we estimated the relative survival (RS) rates and relative excess risk of death among pati
Autor:
Marisol Xandri, Neus Ruiz-Xivillé, Isabel Granada, Llorenç Font, Fuensanta Millá, Montserrat Arnan, Javier Grau, Natalia Lloveras, Adela Cisneros, Diana Campos, Josep-Maria Ribera, Lourdes Escoda
Publikováno v:
Leukemia & Lymphoma. 56:2706-2708
Acute myeloid leukemia (AML) is a heterogeneous group of hematological neoplasms with distinct clinical and genetic features. Chromosomal abnormalities are detectable by conventional cytogenetic an...
Autor:
Anna Bosch-Vizcaya, Nazly Santos, E Tuset, Rosa Coll, Arianne Perez-Garcia, Rocío Rodríguez, Gemma Osca, Nichollas Kelleher, Josep Maria Roncero, Natalia Lloveras, Yolanda González, Maite Serrando, David Gallardo
Publikováno v:
Human Immunology. 74:1219-1224
Cytotoxic T lymphocyte antigen 4 (CTLA-4) plays a key inhibitory role during T lymphocyte activation. The CTLA4 gene is translated into two proteic isoforms: a full-length protein (flCTLA-4) and a soluble counterpart. We explored the expression of bo
Autor:
Yolanda Gonzalez-Montes, Rocío Rodriguez-Romanos, Alicia Villavicencio, Gemma Osca-Gelis, Marta González-Bártulos, Francesca Llopis, Victòria Clapes, Albert Oriol, Anna Sureda, Lourdes Escoda, Josep Sarrà, Ana Garzó, Natàlia Lloveras, Isabel Díez, Isabel Granada, David Gallardo
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Immune dysfunction in patients with multiple myeloma (MM) affects both the innate and adaptive immune system. Molecules involved in the immune checkpoint pathways are essential to determine the ability of cancer cells to escape from the immune system
Externí odkaz:
https://doaj.org/article/83514f73742b4cc29f8593d7f6b6b27a
Autor:
David Cruz, Rocío Rodríguez-Romanos, Marta González-Bartulos, Irene García-Cadenas, Rafael de la Cámara, Inmaculada Heras, Ismael Buño, Nazly Santos, Natàlia Lloveras, Pilar Velarde, Esperanza Tuset, Carmen Martínez, Marcos González, Guillermo F. Sanz, Christelle Ferrá, Antonia Sampol, Rosa Coll, Jose A. Pérez-Simón, Javier López-Jiménez, Manuel Jurado, David Gallardo
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe association of polymorphisms in molecules involved in the immune response (checkpoint inhibitors) with the clinical outcome after allogeneic transplantation (alloHSCT) has been described. Lymphocyte Activation 3 (LAG3) is a surface pr
Externí odkaz:
https://doaj.org/article/edd64b6599aa4fae83967b5ff39bce1c
Autor:
Fuensanta Millá, Josep-Maria Ribera, Blanca Xicoy, Albert Oriol, Natalia Lloveras, José-Tomás Navarro, Guillem Sirera, José-Luis Mate, Evarist Feliu
Publikováno v:
International Journal of Hematology. 86:337-342
In the era of highly active antiretroviral therapy (HAART), the prognosis for acquired immunodeficiency syndrome-related lymphomas (ARL) seems to be similar to that for aggressive B-cell lymphomas in human immunodeficiency virus (HIV)-negative patien
Autor:
Juan-Manuel Sancho, Maite Misis, Pilar Marcos, Mireia Morgades, Josep-Maria Ribera, Evarist Feliu, Natalia Lloveras, Christelle Ferra, Jordi Klamburg, Maria-Luisa Bordeje, Montserrat Batlle, Blanca Xicoy, Albert Oriol
Publikováno v:
International Journal of Hematology. 85:195-202
Patients who are admitted to the intensive care unit (ICU) with hematologic malignancies have a poor prognosis, although outcomes have improved in recent years. This study analyzed ICU mortality, short- and long-term survival, and prognostic factors